ResearcherWellcome Sanger InstituteNo recent work listed
Allan Bradley
Matched on ORCID iD 0000-0002-2349-8839; OpenAlex author ID A5079556556. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper
Papers 3
- Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes. Co-author DOI 10.1038/nature25459↗
- A conditional piggyBac transposition system for genetic screening in mice identifies oncogenic networks in pancreatic cancer. Last author DOI 10.1038/ng.3164↗
- A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer. Co-author DOI 10.1038/nm.3646↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Stefan Eser · 3 shared papers, 2014–2018 · strength 0.11
- Paper Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes. DOI 10.1038/nature25459↗
- Paper A conditional piggyBac transposition system for genetic screening in mice identifies oncogenic networks in pancreatic c… DOI 10.1038/ng.3164↗
- Paper A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer. DOI 10.1038/nm.3646↗
- Roland Michael Schmid · 3 shared papers, 2014–2018 · strength 0.11
- Paper Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes. DOI 10.1038/nature25459↗
- Paper A conditional piggyBac transposition system for genetic screening in mice identifies oncogenic networks in pancreatic c… DOI 10.1038/ng.3164↗
- Paper A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer. DOI 10.1038/nm.3646↗
- Roland Rad · 3 shared papers, 2014–2018 · strength 0.11
- Paper Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes. DOI 10.1038/nature25459↗
- Paper A conditional piggyBac transposition system for genetic screening in mice identifies oncogenic networks in pancreatic c… DOI 10.1038/ng.3164↗
- Paper A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer. DOI 10.1038/nm.3646↗
- Günter Schneider · 3 shared papers, 2014–2018 · strength 0.11
- Paper Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes. DOI 10.1038/nature25459↗
- Paper A conditional piggyBac transposition system for genetic screening in mice identifies oncogenic networks in pancreatic c… DOI 10.1038/ng.3164↗
- Paper A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer. DOI 10.1038/nm.3646↗
- Dieter Saur · 3 shared papers, 2014–2018 · strength 0.11
- Paper Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes. DOI 10.1038/nature25459↗
- Paper A conditional piggyBac transposition system for genetic screening in mice identifies oncogenic networks in pancreatic c… DOI 10.1038/ng.3164↗
- Paper A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer. DOI 10.1038/nm.3646↗
- Nina Schönhuber · 2 shared papers, 2014–2018 · strength 0.08
- Wilko Weichert · 1 shared paper, 2018 · strength 0.05
- Zonera Hassan · 1 shared paper, 2018 · strength 0.05
- Sebastian Lange · 1 shared paper, 2018 · strength 0.05
- Sebastian Mueller · 1 shared paper, 2018 · strength 0.05
- Julia V. Mayerle · 1 shared paper, 2018 · strength 0.05
- Günter Klöppel · 1 shared paper, 2018 · strength 0.05
- Wei Ting Wang · 1 shared paper, 2015 · strength 0.03
- Thomas Knösel · 1 shared paper, 2015 · strength 0.03
- Robert Grützmann · 1 shared paper, 2015 · strength 0.03
- Iréne Esposito · 1 shared paper, 2015 · strength 0.03
- Christian P. Pilarsky · 1 shared paper, 2015 · strength 0.03
- Chang‐Lung Lee · 1 shared paper, 2014 · strength 0.03
- Andrew M. Lowy · 1 shared paper, 2014 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.